A new study revealed that individuals who are taking high amounts of vitamins B6 and B12 would develop Lung Cancer in the long run. The risk of lung cancer is doubled when these supplements are taken regularly. The incidence of developing cancer also increases three to four times in the smoker, the study finds.

Vitamin B6 and B12 can cause cancer

The National Institutes of Health revealed that most people in the United States have enough vitamins B6 and B12 in their diet. However, some groups like vegetarians and elder people might have a deficiency in vitamins B6 and B12.

Hence, these people, especially those with health problems, might need to take a supplement. However, some consumers are taking the vitamins for prevention purposes without knowing the risks that lie ahead.

Theodore Brasky, the study lead author and research assistant professor at Ohio State University, explained that high doses of vitamin B6 and B12 should not be taken as a prevention supplement for lung cancer. This is because it can interact with other medications, and cause harm in men, especially for male smokers. However, the study did not give any firm evidence to prove that the vitamins can directly cause lung cancer. The research did not also explain why there is an increased risk, especially for males.

According to MSN, a new research studied over 77,000 50- to 76-year-old adults in Washington. The volunteers were asked to provide some information about their vitamin supplement in the previous ten years then they were tracked from 2000 to 2002.

The study found out that more than 800 participants, averaging six years of follow-up, developed lung cancer.

The researchers also explained that men, who took more than 20 mg of B6 per day in 10 years, increased the risk of lung cancer by 82% compared to males that did not take any B6 vitamins supplement. Moreover, men who took more than 55 mg per day increased the chance of developing cancer by 98%.

How blood test offers better treatment for lung cancer?

A report published in CBS News revealed that researchers are using blood tests to track genetic changes and markers for tumors. The test will notify a DNA that is released into the blood when cells develop into tumors. The researchers are also detecting the recurrences of cancer up to one year before taking image scans.

Medical personnel is also using the liquid biopsies to analyze cancer. Dr. Charles Swanton explained that liquid biopsies might help identify cancer patients who will or will not benefit from chemotherapy. The test can also give an early warning if a certain treatment is working or not. Hence, this test serves as a guide that will provide a better care for patients with complicated cancer.